Serum Soluble Interleukin–2 Receptor Alpha and RANTES Chemokine as Potential Biomarkers for COVID–19 Infection and Severity
Labib, D., Shahin, R., Samy, L., Elansary, M., Radwan, N., Tamim, H. (2024). Serum Soluble Interleukin–2 Receptor Alpha and RANTES Chemokine as Potential Biomarkers for COVID–19 Infection and Severity. EKB Journal Management System, 33(1), 11-17. doi: 10.21608/ejmm.2024.325650
Dalia A.A. Labib; Rasha M.H. Shahin; Lamees A. Samy; Mohamed G. Elansary; Nada W.A. Radwan; Hend H. Tamim. "Serum Soluble Interleukin–2 Receptor Alpha and RANTES Chemokine as Potential Biomarkers for COVID–19 Infection and Severity". EKB Journal Management System, 33, 1, 2024, 11-17. doi: 10.21608/ejmm.2024.325650
Labib, D., Shahin, R., Samy, L., Elansary, M., Radwan, N., Tamim, H. (2024). 'Serum Soluble Interleukin–2 Receptor Alpha and RANTES Chemokine as Potential Biomarkers for COVID–19 Infection and Severity', EKB Journal Management System, 33(1), pp. 11-17. doi: 10.21608/ejmm.2024.325650
Labib, D., Shahin, R., Samy, L., Elansary, M., Radwan, N., Tamim, H. Serum Soluble Interleukin–2 Receptor Alpha and RANTES Chemokine as Potential Biomarkers for COVID–19 Infection and Severity. EKB Journal Management System, 2024; 33(1): 11-17. doi: 10.21608/ejmm.2024.325650

Serum Soluble Interleukin–2 Receptor Alpha and RANTES Chemokine as Potential Biomarkers for COVID–19 Infection and Severity

Egyptian Journal of Medical Microbiology
Volume 33, Issue 1, January 2024, Page 11-17  XML PDF (423.39 K)
Document Type: New and original researches in the field of Microbiology.
DOI: 10.21608/ejmm.2024.325650
View on SCiNiTO View on SCiNiTO
Authors
Dalia A.A. Labib1; Rasha M.H. Shahin1; Lamees A. Samy1; Mohamed G. Elansary2; Nada W.A. Radwan1; Hend H. Tamim email orcid 1
1Clinical and Chemical Pathology, Faculty of Medicine, Cairo University
2Critical Care Medicine, Faculty of Medicine, Cairo University
Abstract
Background: Even though it seems that the COVID-19 epidemic has ended, the threat of viral mutation and resurgence is still looming. The illness is characterized by acute respiratory distress and other symptoms caused by immune system disturbance and cytokine storm. Objective: We aimed to determine the serum level of soluble Interleukin – 2 Receptor alpha (IL-2Ra) and RANTES in COVID-19 patients. Methodology: A case-control study was performed on 60 patients with a positive nasopharyngeal swab tested by real-time PCR for SARS-CoV-2 and 25 healthy controls to measure serum levels of sIL-2Ra and RANTES using Enzyme-Linked Immunosorbent Assay. Results: The findings showed no significant difference in the serum levels of sIL-2Ra and RANTES between patients and healthy controls, nor was there a difference between severe and non-severe cases of COVID-19. A significant association was observed between the presence of a previous chest condition and the level of RANTES and a significant positive correlation was detected between serum sIL2Ra and RANTES levels. Conclusions: The study analyzed the correlation between the serum sIL2Ra and RANTES, being positively correlated means the same factors influence them and they can be therapeutically targeted in the same way. The effect of a pre-existing chest condition on RANTES level encourages regular monitoring of RANTES. Although the UN WHO has announced that the status of COVID-19 as a public health emergency has been lifted, the virus will always remain a worldwide threat. Therefore, comprehensive research should continue to be better prepared.
Keywords
sIL-2Ra; RANTES; ELISA; COVID-19
Statistics
Article View: 158
PDF Download: 54